Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA approvals
Pharma
With lung cancer FDA nod, it's David versus Goliath
Nuvation Bio has won FDA approval for Ibtrozi, or taletrectinib, to challenge existing meds from Pfizer, BMS and Roche in ROS1-positive lung cancer.
Angus Liu
Jun 11, 2025 4:17pm
Incyte secures anal cancer nods years after FDA rejection
May 16, 2025 10:10am
FDA misses target date for GSK's Nucala in COPD
May 8, 2025 1:39pm
Akeso, AstraZeneca, Ono—Fierce Pharma Asia
May 2, 2025 7:58am
Akeso’s Anniko enters crowded US PD-1 market
Apr 25, 2025 10:55am
FDA asks Novavax for data pledge amid stalled COVID shot review
Apr 23, 2025 9:17am
